SCHEMBL10068259

SCHEMBL10068259

NC(=O)C1C=CC=CC1N

nearest known ligand 0.30

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.30
MAPK1 P28482 1/20 0.30
HSD17B10 Q99714 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17686901 0.79 ABAT (0.31) TSHRMAPK1HSD17B10TDP1
SCHEMBL17695754 0.79 ABAT (0.31) TSHRMAPK1HSD17B10TDP1
SCHEMBL18414293 0.72 EPHX1 (0.33) TDP1
SCHEMBL16247862 0.72
SCHEMBL21162105 0.67
SCHEMBL2535697 0.65
SCHEMBL17366013 0.65
SCHEMBL6278266 0.65
SCHEMBL28180466 0.63
SCHEMBL11579330 0.61 POLB (0.36) TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120088668-A1 THINNING AGENT TAMINCO, NAAMLOZE VENNOOTSCHAP (BE) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088668-A1 THINNING AGENT NAT1, MAP2, AANAT TSHR 2898/4885MAPK1 1708/4885HSD17B10 1260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.